National Cancer Institute (NCI) researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of
Nanomedicine company Nanobiotix has received authorization from the French Medicine Agency to start clinical trials for its drug, NBTXR3, on patients with locally advanced cancers
Advaxis, a developer of immunotherapies for cancer and infectious diseases, has submitted an application for orphan drug designation with the U.S. Food and Drug Administration
A moderate case of obstructive sleep apnea can significantly increase a person’s risk for sudden cardiac death, an often fatal condition in which the heart
The VELscope Vx from LED Medical Diagnostics, parent company of LED Dental, is currently involved in a phase III study designed to determine if fluorescence
Michael Douglas never expected to become a poster boy for head and neck cancer. But he is glad that his recent dispute with a U.K.
Scientists investigating the link between diet and oral cancer have been given a $285,000 boost by healthcare insurance provider Simplyhealth. Simplyhealth is supporting a three-year
The Pennsylvania Department of Health is advising patients of a York County dentist that they might be at risk for infection after an investigation discovered
Spouses and long-term partners of patients with human papillomavirus (HPV)-related oral cancers appear to have no increased risk of oral HPV infections, according to a
LED Medical Diagnostics, the parent company of LED Dental, saw its 2013 first-quarter (end-March 31) revenues decline significantly year-over-year due to a shift in its
Two nutraceuticals — green tea extracts and resveratrol — have shown promise in treating various cancers, including oral squamous cell carcinoma (OSCC). But the limited
Researchers have completed a phase II clinical trial that may help identify patients with human papillomavirus (HPV)-positive oropharyngeal cancer who do not require the full
